AC Immune SA (ACIU) Misses Q4 EPS by 56c

AC Immune SA (NASDAQ: ACIU) reported Q4 EPS of ($0.81), $0.56 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on AC Immune SA (ACIU) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Investing.com’s stocks of the week
• Aspire Biopharma to acquire automotive supplier for $30 million